In silico targeting of colony-stimulating factor-1 receptor: delineating immunotherapy in cancer.

Zahra Azhar Richard Philip Grose Afsheen Raza Zohaib Raza

Published in: Exploration of targeted anti-tumor therapy (2023)

Pyrimidines are potent inhibitors that interact with CSF1R residues. DCC-3014 and ARRY-382 exhibit exceptional pharmaceutical potential exhibiting great structural stability and affinity.

Keyphrases

papillary thyroid
squamous cell
molecular docking
cancer therapy
risk assessment
binding protein
cerebrospinal fluid
climate change